Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1984 1
1985 4
1986 5
1987 2
1988 2
1989 2
1991 3
1992 1
1993 5
1994 1
1995 1
1997 4
1998 2
1999 3
2000 4
2001 2
2002 4
2003 4
2004 2
2005 6
2006 4
2007 13
2008 5
2009 4
2010 12
2011 13
2012 13
2013 6
2014 8
2015 10
2016 6
2017 5
2018 7
2019 4
2020 5
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

162 results
Results by year
Filters applied: . Clear all
Page 1
Bone metastases.
Coleman RE, Croucher PI, Padhani AR, Clézardin P, Chow E, Fallon M, Guise T, Colangeli S, Capanna R, Costa L. Coleman RE, et al. Among authors: clezardin p. Nat Rev Dis Primers. 2020 Oct 15;6(1):83. doi: 10.1038/s41572-020-00216-3. Nat Rev Dis Primers. 2020. PMID: 33060614 Review.
Bone metastasis: mechanisms, therapies, and biomarkers.
Clézardin P, Coleman R, Puppo M, Ottewell P, Bonnelye E, Paycha F, Confavreux CB, Holen I. Clézardin P, et al. Physiol Rev. 2021 Jul 1;101(3):797-855. doi: 10.1152/physrev.00012.2019. Epub 2020 Dec 24. Physiol Rev. 2021. PMID: 33356915
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.
Hadji P, Coleman RE, Wilson C, Powles TJ, Clézardin P, Aapro M, Costa L, Body JJ, Markopoulos C, Santini D, Diel I, Di Leo A, Cameron D, Dodwell D, Smith I, Gnant M, Gray R, Harbeck N, Thurlimann B, Untch M, Cortes J, Martin M, Albert US, Conte PF, Ejlertsen B, Bergh J, Kaufmann M, Holen I. Hadji P, et al. Among authors: clezardin p. Ann Oncol. 2016 Mar;27(3):379-90. doi: 10.1093/annonc/mdv617. Epub 2015 Dec 17. Ann Oncol. 2016. PMID: 26681681 Free article. Review.
miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes.
Croset M, Pantano F, Kan CWS, Bonnelye E, Descotes F, Alix-Panabières C, Lecellier CH, Bachelier R, Allioli N, Hong SS, Bartkowiak K, Pantel K, Clézardin P. Croset M, et al. Among authors: clezardin p. Cancer Res. 2018 Sep 15;78(18):5259-5273. doi: 10.1158/0008-5472.CAN-17-3058. Epub 2018 Jul 24. Cancer Res. 2018. PMID: 30042152 Free article.
The RANK-RANKL axis: an opportunity for drug repurposing in cancer?
Peters S, Clézardin P, Márquez-Rodas I, Niepel D, Gedye C. Peters S, et al. Among authors: clezardin p. Clin Transl Oncol. 2019 Aug;21(8):977-991. doi: 10.1007/s12094-018-02023-5. Epub 2019 Jan 17. Clin Transl Oncol. 2019. PMID: 30656607 Free article. Review.
Bone-Targeted Therapies in Cancer-Induced Bone Disease.
Sousa S, Clézardin P. Sousa S, et al. Among authors: clezardin p. Calcif Tissue Int. 2018 Feb;102(2):227-250. doi: 10.1007/s00223-017-0353-5. Epub 2017 Oct 27. Calcif Tissue Int. 2018. PMID: 29079995 Free article. Review.
Bone metastases in the era of targeted treatments: insights from molecular biology.
Dewulf J, Vangestel C, Verhoeven Y, van Dam P, Elvas F, Van den Wyngaert T, Clézardin P. Dewulf J, et al. Among authors: clezardin p. Q J Nucl Med Mol Imaging. 2019 Jun;63(2):98-111. doi: 10.23736/S1824-4785.19.03203-5. Epub 2019 Jul 11. Q J Nucl Med Mol Imaging. 2019. PMID: 31298015 Free article. Review.
Emerging therapies in bone metastasis.
Clément-Demange L, Clézardin P. Clément-Demange L, et al. Among authors: clezardin p. Curr Opin Pharmacol. 2015 Jun;22:79-86. doi: 10.1016/j.coph.2015.04.004. Epub 2015 May 14. Curr Opin Pharmacol. 2015. PMID: 25935860 Review.
162 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page